Metraipolis › archive › dc_cd57c0c9dcbc
Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42630743
- DOI
- 10.32604/or.2026.083193
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T15:39:52.451Z
- SHA-256 of the archived text
306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3- Stable URL of this page
https://metraipolis.com/documento/dc_cd57c0c9dcbc
How to cite
Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743 — Europe PMC (en), https://europepmc.org/article/MED/42630743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd57c0c9dcbc (Metraipolis archive dc_cd57c0c9dcbc, sha256 306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3)
BibTeX
@misc{dccd57c0c9dcbc,
title = {Prolonged Disease Stability with Durvalumab and Tremelimumab Rechallenge Following Prior Immune Checkpoint Inhibitors: A Case Report — Europe PMC PMID:42630743},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42630743},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd57c0c9dcbc; sha256 306fa8c9646427953776d74a9a2ff40e8ff2b2ec2fab3989711a0349c18d72c3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630743. Agents can read the archived copy with the MCP tool read_document.